briquilimab - SERP Analysis

https://jaspertx.com/briquilimab/

https://ir.jaspertherapeutics.com/news-releases/news-release-details/jasper-therapeutics-announces-late-breaking-briquilimab

https://ir.jaspertherapeutics.com/news-releases/news-release-details/jasper-therapeutics-presents-data-preclinical-briquilimab-study

https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briquilimab

https://touchderma.com/insight/beacon-study-initial-findings-indicate-briquilimab-provides-rapid-and-effective-relief-in-chronic-spontaneous-urticaria/

https://www.globenewswire.com/news-release/2025/01/08/3006120/0/en/Jasper-Therapeutics-Reports-Positive-Data-from-BEACON-Study-of-Briquilimab-in-Chronic-Spontaneous-Urticaria.html

https://ashpublications.org/blood/article/142/Supplement%201/470/501950/Final-Results-from-Phase-1-Study-of-Briquilimab-an

https://pubmed.ncbi.nlm.nih.gov/38972509/

https://www.clinicaltrialsarena.com/news/jasper-trial-briquilimab/

https://www.sciencedirect.com/science/article/pii/S1081120623006956

https://clinicaltrials.eu/inn/briquilimab/

https://www.medchemexpress.com/briquilimab.html?srsltid=AfmBOoqKl3SopDeLL0kRrHWmI9WXDkbgQ6-HFmpzMxzJHXvWHyqF3IXa

https://www.cancer.gov/research/participate/clinical-trials/intervention/briquilimab

http://www.jaspertx.com/wp-content/uploads/2024/06/EMBRN-poster-2024.pdf

https://www.biospace.com/jasper-therapeutics-to-present-data-on-briquilimab-in-mast-cell-driven-diseases-at-the-eaaci-congress-2024

https://thedermdigest.com/spotlight-on-briquilimab-in-cindu-jaspers-anti-cd117-monoclonal-antibody-shows-safety-and-efficacy-in-phase-1b-2a-study/

https://symbioresearch.com/jasper-therapeutics-reports-positive-data-from-beacon-study-of-briquilimab-in-chronic-spontaneous-urticaria/

https://adisinsight.springer.com/drugs/800029529

https://www.globenewswire.com/news-release/2025/06/03/3092716/0/en/Jasper-Therapeutics-Announces-Briquilimab-Presentations-at-the-European-Academy-of-Allergy-and-Clinical-Immunology-EAACI-Annual-Congress.html

https://synapse.patsnap.com/article/jasper-therapeutics-shares-briquilimab-preclinical-study-data-at-2024-eha-congress

https://insights.citeline.com/scrip/r-and-d/clinical-trials/jaspers-briquilimab-stands-up-to-competition-but-investors-bail-LQHFNXKCVJG7NL4HQKMFOPRENU/

https://firstwordpharma.com/story/5903393

https://www.stocktitan.net/news/JSPR/jasper-therapeutics-announces-briquilimab-presentations-at-the-66qbxap3e1xx.html

https://ctv.veeva.com/study/a-phase-2-open-label-extension-study-to-evaluate-long-term-safety-and-clinical-activity-of-briquil

https://thalassaemia.org.cy/news/hsct-briquilimab-granted-orphan-drug-designation-by-the-european-commission/

https://synapse.patsnap.com/article/jasper-therapeutics-shares-briquilimab-data-at-aaaai-annual-meeting

https://www.sahmcapital.com/news/content/jasper-therapeutics-reported-data-from-180mg-cohort-in-spotlight-study-of-briquilimab-in-chronic-inducible-urticaria-11-of-12-participants-enrolled-in-the-180mg-cohort-achieved-a-complete-response-2025-06-14

https://www.sciencedirect.com/science/article/abs/pii/S0006497123050747

https://quantisnow.com/insight/jasper-therapeutics-reports-positive-data-from-180mg-cohort-in-spotlight-study-of-briquilimab-in-6086939

https://jaspertx.com/publications/1401/

https://www.jacionline.org/article/S0091-6749(23)01541-5/fulltext

https://www.thepharmaletter.com/biotechnology/jasper-identifies-path-forward-for-briquilimab

https://ashpublications.org/blood/article/142/Supplement%201/229/501518/Radiation-and-Busulfan-Free-Hematopoietic-Stem

https://www.vjhemonc.com/video/clyuk07s66a-briquilimab-based-conditioning-for-patients-with-fanconi-anemia-receiving-allosct/

https://go.drugbank.com/drugs/DB18136

https://www.healio.com/news/allergy-asthma/20250114/patients-with-chronic-spontaneous-urticaria-see-wellcontrolled-disease-with-briquilimab

https://www.ainvest.com/news/briquilimab-breakthrough-chronic-urticaria-implications-investors-2506/

https://www.nasdaq.com/press-release/jasper-therapeutics-reports-positive-data-spotlight-study-briquilimab-chronic

https://www.ktsm.com/business/press-releases/globenewswire/9387236/jasper-therapeutics-presents-clinical-and-preclinical-briquilimab-data-at-the-american-academy-of-allergy-asthma-and-immunology-aaaai-annual-meeting

https://jaspertx.com/publications/final-results-from-phase-1-study-of-briquilimab-an-anti-cd117-monoclonal-antibody-in-combination-with-low-dose-irradiation-and-fludarabine-conditioning-shows-durable-remissions-in-older-adults-with/

https://finance.yahoo.com/news/jasper-therapeutics-reports-positive-data-140000946.html

https://www.healio.com/news/allergy-asthma/20241213/patients-with-chronic-inducible-urticaria-see-complete-response-to-briquilimab-at-6-weeks

https://www.cbs42.com/business/press-releases/globenewswire/9065361/jasper-therapeutics-announces-first-patient-dosed-in-phase-1b-2a-spotlight-clinical-study-of-briquilimab-in-chronic-inducible-urticaria/

https://www.tristatehomepage.com/business/press-releases/globenewswire/9386553/jasper-therapeutics-announces-late-breaking-briquilimab-presentation-at-the-american-academy-of-dermatology-aad-annual-meeting

https://www.kxnet.com/business/press-releases/globenewswire/9386553/jasper-therapeutics-announces-late-breaking-briquilimab-presentation-at-the-american-academy-of-dermatology-aad-annual-meeting

https://www.taiwannews.com.tw/en/news/6049300

https://www.binghamtonhomepage.com/business/press-releases/globenewswire/9386553/jasper-therapeutics-announces-late-breaking-briquilimab-presentation-at-the-american-academy-of-dermatology-aad-annual-meeting

https://jaspertx.com/about-us/

https://www.investing.com/equities/amplitude-healthcare-acquisition

https://www.uvaldecoop.com/markets/stocks.php?article=globenews-2023-12-10-jasper-therapeutics-presents-positive-final-results-from-phase-1-study-of-briquilimab-in-patients-with-aml-or-mds-undergoing-hematopoietic-cell-transplant-in-oral-presentation-at-ash-2023

https://www.akomnews.com/bbs/board.php?bo_table=news&wr_id=63306

https://m.jnilbo.com/77480768274

https://www.akomnews.com/bbs/board.php?bo_table=news&wr_id=63303

https://endpoints.news/incytes-promising-thrombocythemia-drug-crescent-biopharma-raises-200m-in-pipe/